1. Trang chủ
  2. » Thể loại khác

Ebook Handbook of blood gas/acid-base interpretation: Part 2

160 147 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Cấu trúc

  • Handbook of Blood Gas/Acid-Base Interpretation Second Edition

    • Copyright Page

    • Dedication

    • Preface to the Second Edition

    • Preface to the First Edition

    • Contents

    • Chapter 1: Gas Exchange

      • 1.1 The Respiratory Centre

      • 1.2 Rhythmicity of the Respiratory Centre

      • 1.3 The Thoracic Neural Receptors

      • 1.4 Chemoreceptors

      • 1.5 The Central Chemoreceptors and the Alpha-Stat Hypothesis

      • 1.6 Peripheral Chemoreceptors

      • 1.7 Chemoreceptors in Hypoxia

      • 1.8 Response of the Respiratory Centre to Hypoxemia

      • 1.9 Respiration

      • 1.10 Partial Pressure of a Mixture of Gases

        • 1.10.1 Atmospheric Pressure

        • 1.10.2 Gas Pressure

      • 1.11 Partial Pressure of a Gas

      • 1.12 The Fractional Concentration of a Gas (F gas)

      • 1.13 Diffusion of Gases

      • 1.14 Henry’s Law and the Solubility of a Gas in Liquid

      • 1.15 Inhaled Air

      • 1.16 The O 2 Cascade

      • 1.17 PaO 2

      • 1.18 The Modified Alveolar Gas Equation

      • 1.19 The Determinants of the Alveolar Gas Equation

      • 1.20 The Respiratory Quotient (RQ) in the Alveolar Air Equation

      • 1.21 FIO 2, PAO 2, PaO 2 and CaO 2

      • 1.22 DO 2, CaO 2, SpO 2, PaO 2 and FIO 2

      • 1.23 O 2 Content: An Illustrative Example

      • 1.24 Mechanisms of Hypoxemia

      • 1.25 Processes Dependent Upon Ventilation

      • 1.26 Defining Hypercapnia (Elevated CO 2)

      • 1.27 Factors That Determine PaCO 2 Levels

      • 1.28 Relationship Between CO 2 Production and Elimination

      • 1.29 Exercise, CO 2 Production and PaCO 2

      • 1.30 Dead Space

      • 1.31 Minute Ventilation and Alveolar Ventilation

      • 1.32 The Determinants of the PaCO 2

      • 1.33 Alveolar Ventilation in Health and Disease

      • 1.34 Hypoventilation and PaCO 2

      • 1.35 The Causes of Hypoventilation

      • 1.36 Blood Gases in Hypoventilation

      • 1.37 Decreased CO 2 Production

        • 1.37.1 Summary: Conditions That Can Result in Hypercapnia

      • 1.38 V/Q Mismatch: A Hypothetical Model

      • 1.39 V/Q Mismatch and Shunt

      • 1.40 Quantifying Hypoxemia

      • 1.41 Compensation for Regional V/Q Inequalities

      • 1.42 Alveolo-Arterial Diffusion of Oxygen (A-aDO 2)

      • 1.43 A-aDO 2 is Difficult to Predict on Intermediate Levels of FIO 2

      • 1.44 Defects of Diffusion

      • 1.45 Determinants of Diffusion: DL CO

      • 1.46 Timing the ABG

      • 1.47 A-aDO 2 Helps in Differentiating Between the Different Mechanisms of Hypoxemia

    • Chapter 2: The Non-Invasive Monitoring of Blood Oxygen and Carbon Dioxide Levels

      • 2.1 The Structure and Function of Haemoglobin

      • 2.2 Co-operativity

      • 2.3 The Bohr Effect and the Haldane Effect

      • 2.4 Oxygenated and Non-oxygenated Hemoglobin

      • 2.5 PaO 2 and the Oxy-hemoglobin Dissociation Curve

      • 2.6 Monitoring of Blood Gases

        • 2.6.1 Invasive O 2 Monitoring

        • 2.6.2 The Non-invasive Monitoring of Blood Gases

      • 2.7 Principles of Pulse Oximetry

      • 2.8 Spectrophotometry

      • 2.9 Optical Plethysmography

      • 2.10 Types of Pulse Oximeters

      • 2.11 Pulse Oximetry and PaO 2

      • 2.12 P 50

      • 2.13 Shifts in the Oxy-hemoglobin Dissociation Curve

      • 2.14 Oxygen Saturation (SpO 2) in Anemia and Skin Pigmentation

      • 2.15 Oxygen Saturation (SpO 2) in Abnormal Forms of Hemoglobin

      • 2.16 Mechanisms of Hypoxemia in Methemoglobinemia

      • 2.17 Methemoglobinemias: Classification

      • 2.18 Sulfhemoglobinemia

      • 2.19 Carbon Monoxide (CO) Poisoning

      • 2.20 Saturation Gap

      • 2.21 Sources of Error While Measuring SpO 2

      • 2.22 Point of Care (POC) Cartridges

      • 2.23 Capnography and Capnometry

      • 2.24 The Capnographic Waveform

      • 2.25 Main-Stream and Side-Stream Capnometers

      • 2.26 P Et CO 2 (E t CO 2): A Surrogate for PaCO 2

      • 2.27 Factors Affecting P Et CO 2

      • 2.28 Causes of Increased PaCO 2 -P Et CO 2 Difference

      • 2.29 Bohr’s Equation

      • 2.30 Application of Bohr’s Equation

      • 2.31 Variations in E t CO 2

      • 2.32 False-Positive and False-Negative Capnography

      • 2.33 Capnography and Cardiac Output

      • 2.34 Capnography as a Guide to Successful Resuscitation

      • 2.35 Capnography in Respiratory Disease

      • 2.36 Esophageal Intubation

      • 2.37 Capnography in Tube Disconnection and Cuff Rupture

        • 2.37.1 Biphasic Capnograph

      • References

    • Chapter 3: Acids and Bases

      • 3.1 Intracellular and Extracellular pH

      • 3.2 pH Differences

      • 3.3 Surrogate Measurement of Intracellular pH

      • 3.4 Preferential Permeability of the Cell Membrane

      • 3.5 Ionization and Permeability

      • 3.6 The Reason Why Substances Need to Be Ionized

      • 3.7 The Exceptions to the Rule

      • 3.8 The Hydrogen Ion (H +, Proton)

      • 3.9 Intracellular pH Is Regulated Within a Narrow Range

      • 3.10 A Narrow Range of pH Does Not Mean a Small Range of the H + Concentration

      • 3.11 The Earliest Concept of an Acid

      • 3.12 Arrhenius’s Theory

      • 3.13 Bronsted-Lowry Acids

      • 3.14 Lewis’ Approach

      • 3.15 The Usanovich Theory

      • 3.16 Summary of Definitions of Acids and Bases

      • 3.17 Stewart’s Physico-Chemical Approach

      • 3.18 The Dissociation of Water

      • 3.19 Electrolytes, Non-electrolytes and Ions

      • 3.20 Strong Ions

      • 3.21 Stewart’s Determinants of the Acid Base Status

      • 3.22 Apparent and Effective Strong Ion Difference

      • 3.23 Strong Ion Gap

      • 3.24 Major Regulators of Independent Variables

      • 3.25 Fourth Order Polynomial Equation

      • 3.26 The Workings of Stewart’s Approach

    • Chapter 4: Buffer Systems

      • 4.1 Generation of Acids

      • 4.2 Disposal of Volatile Acids

      • 4.3 Disposal of Fixed Acids

      • 4.4 Buffer Systems

      • 4.5 Buffers

      • 4.6 Mechanisms for the Homeostasis of Hydrogen Ions

      • 4.7 Intracellular Buffering

      • 4.8 Alkali Generation

      • 4.9 Buffer Systems of the Body

      • 4.10 Transcellular Ion Shifts with Acute Acid Loading

      • 4.11 Time-Frame of Compensatory Responses to Acute Acid Loading

      • 4.12 Quantifying Buffering

      • 4.13 Buffering in Respiratory Acidosis

      • 4.14 Regeneration of the Buffer

      • 4.15 Buffering in Alkalosis

      • 4.16 Site Buffering

      • 4.17 Isohydric Principle

      • 4.18 Base–Buffering by the Bicarbonate Buffer System

      • 4.19 Bone Buffering

      • 4.20 Role of the Liver in Acid–Base Homeostasis

      • References

    • Chapter 5: pH

      • 5.1 Hydrogen Ion Activity

      • 5.2 Definitions of the Ad-hoc Committee of New York Academy of Sciences, 1965

      • 5.3 Acidosis and Alkalosis

      • 5.4 The Law of Mass Action

      • 5.5 Dissociation Constants

      • 5.6 pK

      • 5.7 The Buffering Capacity of Acids

        • 5.7.1 Buffering Power

      • 5.8 The Modified Henderson-Hasselbach Equation

      • 5.9 The Difficulty in Handling Small Numbers

      • 5.10 The Puissance Hydrogen

      • 5.11 Why pH?

      • 5.12 Relationship Between pH and H +

      • 5.13 Disadvantages of Using a Logarithmic Scale

      • 5.14 pH in Relation to pK

      • 5.15 Is the Carbonic Acid System an Ideal Buffer System?

      • 5.16 The Bicarbonate Buffer System Is Open Ended

      • 5.17 Importance of Alveolar Ventilation to the Bicarbonate Buffer System

      • 5.18 Difference Between the Bicarbonate and Non-bicarbonate Buffer Systems

      • 5.19 Measuring and Calculated Bicarbonate

    • Chapter 6: Acidosis and Alkalosis

      • 6.1 Compensation

      • 6.2 Coexistence of Acid Base Disorders

      • 6.3 Conditions in Which pH Can Be Normal

      • 6.4 The Acid Base Map

    • Chapter 7: Respiratory Acidosis

      • 7.1 Respiratory Failure

      • 7.2 The Causes of Respiratory Acidosis

      • 7.3 Acute Respiratory Acidosis: Clinical Effects

      • 7.4 Effect of Acute Respiratory Acidosis on the Oxy-hemoglobin Dissociation Curve

      • 7.5 Buffers in Acute Respiratory Acidosis

      • 7.6 Respiratory Acidosis: Mechanisms for Compensation

      • 7.7 Compensation for Respiratory Acidosis

      • 7.8 Post-hypercapnic Metabolic Alkalosis

      • 7.9 Acute on Chronic Respiratory Acidosis

      • 7.10 Respiratory Acidosis: Acute or Chronic?

    • Chapter 8: Respiratory Alkalosis

      • 8.1 Respiratory Alkalosis

      • 8.2 Electrolyte Shifts in Acute Respiratory Alkalosis

      • 8.3 Causes of Respiratory Alkalosis

      • 8.4 Miscellaneous Mechanisms of Respiratory Alkalosis

      • 8.5 Compensation for Respiratory Alkalosis

      • 8.6 Clinical Features of Acute Respiratory Alkalosis

    • Chapter 9: Metabolic Acidosis

      • 9.1 The Pathogenesis of Metabolic Acidosis

      • 9.2 The pH, PCO 2 and Base Excess: Relationships

      • 9.3 The Law of Electroneutrality and the Anion Gap

      • 9.4 Electrolytes and the Anion Gap

      • 9.5 Electrolytes That Influence the Anion Gap

      • 9.6 The Derivation of the Anion Gap

      • 9.7 Calculation of the Anion Gap

      • 9.8 Causes of a Wide-Anion-Gap Metabolic Acidosis

      • 9.9 The Corrected Anion Gap (AG c)

      • 9.10 Clues to the Presence of Metabolic Acidosis

      • 9.11 Normal Anion-Gap Metabolic Acidosis

      • 9.12 Pathogenesis of Normal-Anion Gap Metabolic Acidosis

      • 9.13 Negative Anion Gap

      • 9.14 Systemic Consequences of Metabolic Acidosis

      • 9.15 Other Systemic Consequences of Metabolic Acidosis

      • 9.16 Hyperkalemia and Hypokalemia in Metabolic Acidosis

      • 9.17 Compensatory Response to Metabolic Acidosis

      • 9.18 Compensation for Metabolic Acidosis

      • 9.19 Total CO 2 (TCO 2)

      • 9.20 Altered Bicarbonate Is Not Specific for a Metabolic Derangement

      • 9.21 Actual Bicarbonate and Standard Bicarbonate

      • 9.22 Relationship Between ABC and SBC

      • 9.23 Buffer Base

      • 9.24 Base Excess

      • 9.25 Ketosis and Ketoacidosis

      • 9.26 Acidosis in Untreated Diabetic Ketoacidosis

      • 9.27 Acidosis in Diabetic Ketoacidosis Under Treatment

      • 9.28 Renal Mechanisms of Acidosis

      • 9.29 l -Lactic Acidosis and d -Lactic Acidosis

      • 9.30 Diagnosis of Specific Etiologies of Wide Anion Gap Metabolic Acidosis

      • 9.31 Pitfalls in the Diagnosis of Lactic Acidosis

      • 9.32 Renal Tubular Acidosis

      • 9.33 Distal RTA

      • 9.34 Mechanisms in Miscellaneous Causes of Normal Anion Gap Metabolic Acidosis

      • 9.35 Toxin Ingestion

      • 9.36 Bicarbonate Gap (the Delta Ratio)

      • 9.37 Urinary Anion Gap

      • 9.38 Utility of the Urinary Anion Gap

      • 9.39 Osmoles

      • 9.40 Osmolarity and Osmolality

      • 9.41 Osmolar Gap

      • 9.42 Abnormal Low Molecular Weight Circulating Solutes

      • 9.43 Conditions That Can Create an Osmolar Gap

      • Reference

    • Chapter 10: Metabolic Alkalosis

      • 10.1 Etiology of Metabolic Alkalosis

      • 10.2 Pathways Leading to Metabolic Alkalosis

      • 10.3 Maintenance Factors for Metabolic Alkalosis

      • 10.4 Maintenance Factors for Metabolic Alkalosis: Volume Contraction

      • 10.5 Maintenance Factors for Metabolic Alkalosis: Dyselectrolytemias

      • 10.6 Compensation for Metabolic Alkalosis

      • 10.7 Urinary Sodium

      • 10.8 Diagnostic Utility of Urinary Chloride (1)

      • 10.9 The Diagnostic Utility of Urinary Chloride (2)

      • 10.10 Diagnostic Utility of Urinary Chloride (3)

      • 10.11 Some Special Causes of Metabolic Alkalosis

      • 10.12 Metabolic Alkalosis Can Result in Hypoxemia

      • 10.13 Metabolic Alkalosis and the Respiratory Drive

    • Chapter 11: The Analysis of Blood Gases

      • 11.1 Normal Values

        • 11.1.1 Venous Blood Gas (VBG) as a Surrogate for ABG Analysis

      • 11.2 Step 1: Authentication of Data

      • 11.3 Step 2: Characterization of the Acid-Base Disturbance

      • 11.4 Step 3: Calculation of the Expected Compensation

      • 11.5 The Alpha-Numeric (a-1) Mnemonic

      • 11.6 The Metabolic Track

      • 11.7 The Respiratory Track

      • 11.8 Step 4: The ‘Bottom Line’: Clinical Correlation

        • 11.8.1 Clinical Conditions Associated with Simple Acid-Base Disorders

        • 11.8.2 Mixed Disorders

      • 11.9 Acid-Base Maps

    • Chapter 12: Factors Modifying the Accuracy of ABG Results

      • 12.1 Electrodes

      • 12.2 Accuracy of Blood Gas Values

      • 12.3 The Effects of Metabolizing Blood Cells

      • 12.4 Leucocyte Larceny

      • 12.5 The Effect of an Air Bubble in the Syringe

      • 12.6 Effect of Over-Heparization of the Syringe

      • 12.7 The Effect of Temperature on the Inhaled Gas Mixture

      • 12.8 Effect of Pyrexia (Hyperthermia) on Blood Gases

      • 12.9 Effect of Hypothermia on Blood Gases

      • 12.10 Plastic and Glass Syringes

    • Chapter 13: Case Examples

      • 13.1 Patient A: A 34 year-old man with Metabolic Encephalopathy

      • 13.2 Patient B: A 40 year-old man with Breathlessness

      • 13.3 Patient C: A 50 year-old woman with Hypoxemia

      • 13.4 Patient D: A 20 year-old woman with Breathlessness

      • 13.5 Patient E: A 35 year-old man with Non-resolving Pneumonia

      • 13.6 Patient F: A 60 year-old man with Cardiogenic Pulmonary Edema

      • 13.7 Patient G: A 72 year-old Drowsy COPD Patient

      • 13.8 Patient H: A 30 year-old man with Epileptic Seizures

      • 13.9 Patient I: An Elderly Male with Opiate Induced Respiratory Depression

      • 13.10 Patient J: A 73 year-old man with Congestive Cardiac Failure

      • 13.11 Patient K: A 20 year-old woman with a Normal X-ray

      • 13.12 Patient L: A 22 year-old man with a Head Injury

      • 13.13 Patient M: A 72 year-old man with Bronchopneumonia

      • 13.14 Patient N: A 70 year-old woman with a Cerebrovascular Event

      • 13.15 Patient O: A 60 year-old man with COPD and Cor Pulmonale

      • 13.16 Patient P: A 70 year-old smoker with Acute Exacerbation of Chronic Bronchitis

      • 13.17 Patient Q: A 50 year-old man with Hematemesis

      • 13.18 Patient R: A 68 year-old man with an Acute Abdomen

      • 13.19 Patient S: A young woman with Gastroenteritis and Dehydration

      • 13.20 Patient T: A 50 year-old woman with Paralytic Ileus

      • 13.21 Patient U: An 80 year-old woman with Extreme Weakness

      • 13.22 Patient V: A 50 year-old man with Diarrhea

      • 13.23 Patient W: A 68 year-old woman with Congestive Cardiac Failure

      • 13.24 Patient X: An 82 year-old woman with Diabetic Ketoacidosis

      • 13.25 Patient Y: A 50 year-old male in Cardiac Arrest

      • 13.26 Patient Z: A 50 year-old Diabetic with Cellulitis

    • Index

Nội dung

(BQ) Part 2 book Handbook of blood gas/acid-base interpretation has contents: Respiratory acidosis, respiratory alkalosis, metabolic acidosis, the analysis of blood gases, the analysis of blood gases, case examples,... and other contents

Chapter Respiratory Acidosis Contents 7.1 7.2 7.3 7.4 Respiratory Failure The Causes of Respiratory Acidosis Acute Respiratory Acidosis: Clinical Effects Effect of Acute Respiratory Acidosis on the Oxy-hemoglobin Dissociation Curve 7.5 Buffers in Acute Respiratory Acidosis 7.6 Respiratory Acidosis: Mechanisms for Compensation 7.7 Compensation for Respiratory Acidosis 7.8 Post-hypercapnic Metabolic Alkalosis 7.9 Acute on Chronic Respiratory Acidosis 7.10 Respiratory Acidosis: Acute or Chronic? 172 173 174 A Hasan, Handbook of Blood Gas/Acid-Base Interpretation, DOI 10.1007/978-1-4471-4315-4_7, © Springer-Verlag London 2013 171 175 176 176 177 178 179 180 172 7.1 Respiratory Acidosis Respiratory Failure Although four types of respiratory failure have been described, it is usual to classify respiratory failure into Type-1 and Type-2: the latter is associated with hypoventilation and respiratory acidosis (see Sect 7.2) Respiratory failure Type (Hypoxemic respiratory failure) Type (Hypercapnic respiratory failure) PaO2 is low (PaO2 < 50 mmHg) PaO2 is low (PaO2 < 50 mmHg) CO2 is not elevated (PaCO2 < 60 mmHg) CO2 is elevated (PaCO2 > 60 mmHg) See Sect 1.25 See Sect 1.26 Type (Per-operative respiratory failure) FRC falls below closing volume as a result of atelectasis Contributing factors: Supine posture General anesthesia Depressed cough reflex Splinting due to pain Type (Shock with hypo perfusion) The proportion of the cardiac output to the respiratory muscles rises by as much as ten-fold when the work of breathing is high; this can seriously impair coronary perfusion during shock 7.2 7.2 173 The Causes of Respiratory Acidosis The Causes of Respiratory Acidosis In terms of CO2 production and excretion, alveolar hypoventilation is the major mechanism for hypercarbia (See Sects 1.34 and 1.35) Quite often however, increase in dead space is an important mechanism (Sect 1.30) Causes of acute hypercapnia Central depression of respiratory drive Drugs Sedatives, opiates, anaesthetic agents CNS lesions CNS trauma, strokes, encephalitis Neuromuscular Spinal cord lesions or trauma (at or above level of C4) High central neural blockade Tetanus Poliomyelitis Amyotrophic lateral sclerosis Myasthenia gravis Organophosphate poisoning Botulism Muscular relaxants Dyselectreolytemias Airways Upper airway obstruction Aspiration Asthma or COPD Chest wall Flail chest Diaphragmatic dysfunction: Paralysis Splinting Rupture Pleura Pneumothorax Rapid accumulation of a large pleural effusion Lung parenchyma Cardiogenic pulmonary edema ARDS Pneumonia Other Circulatory shock Sepsis Malignant hyperthermia CO2 insufflation into the body Causes of chronic hypercapnia Central depression of respiratory drive Primary alveolar hypoventilation Neuromuscular Chronic neuromyopathies Poliomyelitis Dyselectreolytemias Malnutrition Chest wall Kyphoscoliosis Obesity Thoracoplasty Pleura Chronic large effusions Lung parenchyma Longstanding and severe ILD Airways Persistent asthma Severe COPD Bronchiectasis 174 7.3 Respiratory Acidosis Acute Respiratory Acidosis: Clinical Effects A rapid decrease in alveolar ventilation is poorly tolerated by the body Both acute hypercapnia and acute hypoxemia can be extremely damaging However, surprising degrees of hypercapnia and hypoxemia can be tolerated by the body when chronic Acute Chronic • Poorly tolerated: can result in dangerous fluxes in the acid base status of the body • Relatively well tolerated: due to compensatory mechanisms; patients may remain asymptomatic with very high PaCO2 levels (e.g., over 100 mmHg) Most clinical manifestations of acute hypercapnia are to with the central nervous system Clinical features of Hypercapnia Sympahetic stimulation Tachycardia, arrythmias Sweating Reflex peripheral vasoconstriction Peripheral vasodilatation (a direct effect of hypercapnia) Headaches, hypotension (if hypercapnia is severe) Central depression (occurs at very high CO2 levels) Drowsiness, flaps, coma Decreased diaphragmatic contractility & endurance Respiratory muscle fatigue Cerebral vasodilatation (results in increased intracranial pressure) Confusion, headache; papilledema, loss of consciousness (if severe); hyperventilation Alberti E, Hoyer S, Hamer J, Stoeckel H, Packschiess P, Weinhardt F The effect of carbon dioxide on cerebral blood flow and cerebral metabolism in dogs Br J Anaesth 1975;47:941–7 Kilburn KH Neurologic manifestations of respiratory failure Arch Intern Med 1965;116: 409–15 Neff TA, Petty TL Tolerance and survival in severe chronic hypercapnia Arch Intern Med 1972; 129:591–6 Smith RB, Aass AA, Nemoto EM Intraocular and intracranial pressure during respiratory alkalosis and acidosis Br J Anaesth 1981;53:967–72 7.4 7.4 Effect of Acute Respiratory Acidosis on the Oxy-hemoglobin Dissociation Curve 175 Effect of Acute Respiratory Acidosis on the Oxy-hemoglobin Dissociation Curve Acute hypercapnia can transiently shift the oxy-hemoglobin dissociation curve to the right Acute hypercapnia The oxy-Hb dissociation curve shifts rightwards When hypercapnia becomes chronic, 2,3 DPG levels within RBC fall The oxy-Hb dissociation curve shifts back towards normal Respiratory acidosis can decrease glucose uptake in peripheral tissues, and inhibit anaerobic glycolysis When severe hypoxia is present, energy requirements can be critically compromised Bellingham AJ, Detter JC, Lenfant C Regulatory mechanisms of hemoglobin oxygen affinity in acidosis and alkalosis J Clin Invest 1971;50:700–6 Oski FA, Gottlieb AJ, Delivoria-Papadopoulos M, Miller WW Red-cell 2, 3-diphosphoglycerate levels in subjects with chronic hypoxemia N Engl J Med 1969;280:1165–6 176 7.5 Respiratory Acidosis Buffers in Acute Respiratory Acidosis The bicarbonate buffer system, quantitatively the most important buffer system in the body, cannot buffer changes produced by alterations in CO2, one of its own components CO2 changes are buffered therefore by non-bicarbonate buffer systems Hemoglobin Intracellular proteins and phosphates About 99 % of the buffering occurs intracellularly Phosphates 7.6 Respiratory Acidosis: Mechanisms for Compensation Hypercapnia CO2 + H2O The elevated PaCO2 stimulates alveolar ventilation Intracellular buffering (rapid) H2CO3 + Hb H+Hb + HCO3– H2CO3 H+ + HCO3– Renal compensation (delayed) H+ is excreted by the kidney Brackett NC Jr, Wingo CF, Mureb O, et al Acid-base response to chronic hypercapnia in man New Eng J Med 1969;280:124–30 7.7 177 Compensation for Respiratory Acidosis 7.7 Compensation for Respiratory Acidosis The following formulae are used to determine the extent of the compensatory processes, or if a second primary acid-base disorder is present Acute respiratory acidosis (24 h) • Δ↓∗pH = 0.008 ì PaCO2 pH = 0.003 ì PaCO2 H+ = 0.8 ì PaCO2 H+ = 0.3 ì ΔPaCO2 • HCO3− increases by up to 0.1 mEq/L for every mmHg rise in CO2 • HCO3− increases by up to 0.4 mEq/L for every mmHg rise in CO2 • H+ = (0.8 ì PaCO2) + H+ = (0.3 × PaCO2) + 27 Limits of compensation for respiratory acidosis • The process of compensation is generally complete within − days • The bicarbonate illy A metabolic alkalosis may be masking the acidosis, and the bicarbonate gap must now be checked B Bicarbonate gap: DAG – DHCO3– = (27–12) – (24–21) = 12 (i.e., >6mEq/L) An associated metabolic alkalosis is present Acute respiratory acidosis: C Colloid gap: Acute respiratory alkalosis: D Disorder, associated primary respiratory: Acute respiratory alkalosis: Expected HCO3– = 24 – [(40 – CO2) × 0.2] = 21 (This identical to the measured HCO3 No associated metabolic disorder is apparent However see anion gap and bicarbonate gap (top left) E Electrolytes, urinary: Chronic respiratory alkalosis: O Clinical correlation: All causes of a wide anion gap metabolic acidosis (Sect 9.8) must be investigated The Bicarbonate gap is wide as well The patient has been vomiting, and on account of this, the third disorder—a coexistent met alkalosis-has supervened The hypoxemia is likely on account of the congestive cardiac failure and pulmonary edema 13 13.24 321 Patient X: An 82 year-old woman with Diabetic Ketoacidosis 13.24 Patient X: An 82 year-old woman with Diabetic Ketoacidosis A 82 year old woman was admitted in diabetic ketoacidosis; she had been coughing and breathless for a few days, and a right lower lobe pneumonia was found at admission pH: 7.35, PCO2: 25 mmHg, HCO3−: 18 mEq/L, Na+: 141 mEq/L, Cl−: 89 mEq/L, PaO2 82 mmHg on 50 % O2, 100 7.0 90 12 15 18 21 24 27 7.1 80 sis o cid 70 olic tab Me idosis ac 60 H– (nM/L) ry N onic Chr iratory resp alosis alk 30 20 10 e ut Ac re on Chr Metabolic alkalosis is os e ut kal Ac y al r o at pir 7.2 39 sis 42 45 48 51 57 63 69 75 pH ido y ac r irato sp ic re 33 36 ir sp 50 40 a o at 30 7.3 7.4 7.5 7.6 7.7 7.8 s re [H m CO Eq – /L ] 8.0 8.5 10 20 30 40 50 60 70 80 90 100 PCO2 (mmHg) Patient X Impression: metabolic acidosis with chronic respiratory alkalosis In fact, a triple disorder is present (see discussion opposite) 13 322 13 Case Examples pH 7.36: mildly acidemic A B C D E Is metabolic acidosis present (is the bicarbonate low?) Is respiratory acidosis present (is the PaCO2 high?) Yes, marginally A dominant metabolic acidosis is possibly present: Apply the METABOLIC TRACK No Anion gap: AG=[Na+] – ([Cl–] + [HCO3–]) = 141 – (89 + 18) = 34 The anion gap is widened The acidosis is a WAGMA Bicarbonate gap: Is an associated metabolic alkalosis present? Calculate the bicarbonate gap (delta ratio) Delta ratio= ΔAG – ΔHCO3– Delta ratio= (34 – 12) – (24 – 18)=16 (very high) A coexisting metabolic alkalosis is present Colloid gap: Disorder, associated primary respiratory: Is an associated respiratory disorder present? Actual CO2 = 25 Predicted CO2 = (1.5 × HCO3) + 8±2 = 35±2 mmHg Actual CO2 (25 mmHg) is lower than the predicted CO2 (33–37) A primary respiratory alkalosis is present Electrolytes, urinary: Clinical correlation: DKA presents with a wide anion gap metabolic acidosis However there is a discrepancy: the substantially widened AG suggests a severe metabolic acidosis which is seemingly out of proportion to the mild depression in the serum bicarbonate.A coexisting metabolic alkalosis was suspected and confirmed (see also Sect 9.36) To explain the metabolic alkalosis, dyselectrolytemias (hypochloremia, hypokalemia) should be looked for, and a history of current diuretic therapy etc must be sought The respiratory alkalosis is consistent with the pneumonia 13 323 13.25 Patient Y: A 50 year-old male in Cardiac Arrest 13.25 Patient Y: A 50 year-old male in Cardiac Arrest A 50 year old male suffers a cardiopulmonary arrest in the ICU pH 7.0, HCO3−: 6.0 PCO2: 29 mmHg, PaO2 180 mmHg on FIO2 100 % on ventilator Na+: 144 mEq/L, K+: 5.0 mEq/L, Cl−: 104 mEq/L 7.0 100 90 12 15 18 21 24 27 7.1 80 sis o cid 70 olic tab Me idosis ac 60 H− (nM/L) ry te N onic Chr iratory resp alosis alk 30 20 10 re u Ac on Chr Metabolic alkalosis is os e ut kal Ac y al r o at pir 7.2 39 sis 42 45 48 51 57 63 69 75 pH ido y ac r irato sp ic re 33 36 ir sp 50 40 a o at 30 7.3 7.4 7.5 7.6 7.7 7.8 s re [H m CO Eq − /L ] 8.0 8.5 10 20 30 40 50 60 70 80 90 100 PCO2 (mmHg) Patient Y Severe metabolic acidosis with acute respiratory alkalosis 13 ... ingestion, 23 1 types, 22 3 UAG, 23 3 23 4 WAGMA, 22 5 systemic consequences, 20 8 20 9 TCO2, 21 4 Metabolic alkalosis acute abdomen, 315–316 causes, 25 2 compensation, 24 7, 26 1 diuretic usage, 321 – 322 electrolytes,... in, 21 5 21 7 anion gap in, 26 3 base excess in, 21 9 bicarbonate gap in, 26 3 buffer base in, 21 8 cardiopulmonary arrest and, 329 –330 colloid gap in, 26 3 compensation, 21 2 21 3, 26 1 diarrhea, 323 – 324 ... seizure, 29 5 29 6 hyperkalemia and hypokalemia, 21 1 indicators, 20 4 l-lactic acidosis and d-lactic acidosis, 22 4, 22 7 pathogenesis, 195 renal mechanisms NAGMA, 23 0 renal tubular acidosis, 22 8 22 9 toxin

Ngày đăng: 21/01/2020, 14:53